Loading…

Implementation of a High-Resolution Liquid Chromatography–Mass Spectrometry Method in Quality Control Laboratories for Release and Stability Testing of a Commercial Antibody Product

Liquid chromatography–mass spectrometry (LC–MS) has been widely used throughout biotherapeutic development. However, its implementation in GMP-compliant commercial quality control (QC) laboratories remains a challenge. In this publication, we describe the covalidation and implementation of an automa...

Full description

Saved in:
Bibliographic Details
Published in:Analytical chemistry (Washington) 2020-02, Vol.92 (3), p.2369-2373
Main Authors: Sokolowska, Izabela, Mo, Jingjie, Rahimi Pirkolachahi, Fatie, McVean, Carol, Meijer, Lars A. T, Switzar, Linda, Balog, Crina, Lewis, Michael J, Hu, Ping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liquid chromatography–mass spectrometry (LC–MS) has been widely used throughout biotherapeutic development. However, its implementation in GMP-compliant commercial quality control (QC) laboratories remains a challenge. In this publication, we describe the covalidation and implementation of an automated, high-throughput, and GMP compliant subunit LC–MS method for monitoring antibody oxidation for commercial product release and stability testing. To our knowledge, this is the first report describing the implementation of a high-resolution LC–MS method in commercial QC laboratories for product release and stability testing in the biopharmaceutical industry. This work paves the road for implementing additional LC–MS methods to modernize testing in commercial QC with more targeted control of product quality.
ISSN:0003-2700
1520-6882
DOI:10.1021/acs.analchem.9b05036